The goal isn't just to hide the rednessit's to actively reduce your body's exposure to a known toxin
Users with longer treatment duration (6+ months) typically stabilize at plateau maintaining 40-60% of peak improvements, while short-term users (under 3 months) often continue gradual decline approaching pre-treatment baseline by month 4-6
word-finding)
The expressions of PGs, including PGD2, PGE2, PGF2, PGI2, PGJ2, and TXA2, are abnormal in RA (20)
How to read preclinical evidence without over-reading it Preclinical does not mean worthless it means early
The driver may be mast-cell-mediated or systemic rather than NF-B-local, and if so, increasing the dose for additional KPV will not address it see the mast-cell note under Phenotype Considerations